|
GB0608766D0
|
|
Pyrido (3,2-D) pyrimidines useful for making pharmaceutical compositions for treating hepatitus C
|
|
GB0603585D0
|
|
Pteridines for use in the manufacture of a medicament for treating inflammatory bowel diseases
|
|
GB0503506D0
|
|
Substituted pyrido(2,3-d) pyrimidine derivatives and pharmaceutical compositions useful as medicines for the treatment of autoimmune disorders
|
|
GB0428581D0
|
|
Pyrido(3,2-D) pyrimidine derivatives and pharmaceutical compositions useful as medicines fir the treatment of autoimmune disorders
|
|
GB0428475D0
|
|
Pyrido(3,2-D)pyrimidine derivatives and pharmaceutical compositions useful as medicines for the treatment of autoimmune disorders
|
|
CA2537224A1
|
|
Heterocycle-substituted pteridine derivatives and their use in therapy
|
|
AU2004271721A1
|
|
Pteridine derivatives for the treatment of septic shock and TNF-alpha-related diseases.
|
|
WO2005021003A2
|
|
Immunosuppressive effects of pteridine derivatives
|
|
GB0408955D0
|
|
Pharmaceutically active pteridine derivatives
|
|
GB0324324D0
|
|
Pteridine derivatives
|
|
GB0321384D0
|
|
Pteridine derivatives for treating TNF-alpha related disorders
|
|
US7276506B2
|
|
Immunosuppressive effects of pteridine derivatives
|
|
US6946465B2
|
|
Immunosuppressive effects of pteridine derivatives
|
|
EP1144412A1
|
|
Immunosuppressive effects of pteridine derivatives
|
